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Abstract
Anterior cervical discectomy and fusion (ACDF) has long been considered the gold
standard for treating myelopathy and radiculopathy due to disk degeneration. One
major complication of this procedure is adjacent segment degeneration. Cervical disc
arthroplasty (CDA) has been proposed as an alternative to ACDF and as a means to
reduce ASD. This chapter briefly recounts the advent of CDA. Additionally, it
describes the most common implants and biomechanical properties associated with
those designs. Critical to CDA is meticulous operative technique including implant
positioning and hemostasis. Data in the form of FDA IDE studies and more recent
meta-analyses of existing studies have demonstrated non-inferiority of CDA when
compared to ACDF. This chapter also reviews the most common complications
associated with CDA including heterotopic ossification and ankylosis of the involved
segment. While more technically demanding than ACDF, CDA does represent a viable
alternative in the proper patient.
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1. Introduction
Anterior cervical discectomy and fusion (ACDF) has long been considered the gold standard
for treating myelopathy and radiculopathy due to disk degeneration [1]. Secondary to this
success it has become the archetype by which all subsequent techniques are judged. The clinical
success of ACDF is evident across the literature, reaching as far back as the middle of the last
century [1-4].
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
As with any surgical intervention, ACDF is not without its complications. The most notable
of these complications is adjacent segment degeneration (ASD). Described as the radiographic
appearance of degenerative changes above or below a fused segment, this anomaly has a
reported incidence of up to 92% in some studies [5]. Instrumental in its management is
understanding the difference between adjacent segment degeneration and adjacent segment
disease. The latter being degeneration severe enough to cause clinical symptoms and/or
require surgical intervention [6]. Keeping this distinction in mind, Hilibrand et al. [6] described
a 3% chance of symptomatic ASD per year following ACDF. In the symptomatic group
approximately two thirds required a repeat surgery. Taking the group as a whole, 25%
demonstrated new symptoms within 10 years of the index procedure. Goffin et al. [7] dem‐
onstrated similar rates of ASD between older patients treated for degeneration and younger
patients treated in the traumatic setting. Combining this data with the biomechanical studies
demonstrating increased motion and intradiscal pressures at juxtafusional levels, it stands to
reason that altered biomechanics following ACDF may play a role in ASD.
Complications related to graft materials have also come under scrutiny. In addition to
increased operative time, iliac crest harvest has been linked to numerous complications
including donor site pain, infection, nerve injury, and pelvic fracture [8, 9]. While allograft
options do eliminate the risks listed above it does carry the risk of disease transmission [10].
Nonunion is also a risk associated with ACDF. Rates of 3%-11% have been reported in the
literature for single-level fusions with rates increasing to over 25% in multi-level cases [1, 11].
It is with these complications in mind, that alternatives to fusion have come to the forefront in
treating cervical degenerative disease.
Cervical disk arthroplasty (CDA) has come of age over the last two decades. From its crude
beginnings in the 1950’s, through its re-emergence in the late 80’s and 90’s, CDA has evolved
to include multiple devices and bearing options. The following chapter will work to describe
the most clinically relevant implants, outline the current state of the art, and highlight the
results of landmark studies for this emerging procedure.
2. Implants
The implants described in the following section were chosen based on relevant data that will
be described in the clinical outcomes section. It is not meant to be a representation of all
available devices.
2.1. The Porous-Coated Motion Cervical arthroplasty (PCM) (Figure 1)
The PCM made by Nuvasive (San Diego, California) consists of a cobalt-chrome-molybdenum
(CrCoMo) alloy with an ultra-high molecular weight polyethylene (UHMWPE) insert. The
concave surface of the superior endplate articulates with the convex superior surface of the
polyethylene over a large radius of curvature. The endplates have a coating of titanium/
calcium phosphate in addition to serrated edges to promote ingrowth. The disk is designed to
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match the natural contour of the uncovertebral joint. This design allows for minimal limitations
of range of motion and minimal constraint.
Figure 1. PCM (Courtesy of Nuvasive, San Diego, California)
2.2. ProDisc-C (Figure 2)
ProDisc-C made by Synthes (West Chester, Pennsylvania) has a ball and socket design, with
endplates made of a cobalt-chrome alloy. Initial fixation comes from keels on each endplate
combined with titanium plasma spray to promote bony in-growth. The bearing surface has an
articulating dome of UHMWPE secured to the inferior endplate and a concave socket integral
to the superior endplate. The implant allows for motion only in a specific range.
Figure 2. ProDisc-C (Courtesy of Synthes Spine, West Chester, Pennsylvania)
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2.3. Bryan cervical disc prosthesis (Figure 3)
Bryan Cervical Disc Prosthesis made by Medtronic Sofamor Danek (Memphis, Tennessee)
consists of a nucleus made of polyurethane between two titanium alloy endplates in a clamshell
configuration. The two bearing surfaces in the arthroplasty at the interfaces between the
nucleus and the endplates are contained by a polyurethane sheath that attaches to the
endplates. Sterile saline is injected between the outer sheath and the nucleus as lubricant as
part of the implantation. Ideally, this sheath contains any wear debris and prevents soft tissue
in-growth. The endplates have a titanium porous coating and a flange to prevent migration.
This implant is unconstrained.
Figure 3. Bryan Cervical Disc (Courtesy of Medtronic Sofamor Danek, Memphis, Tennessee)
2.4. Prestige (Figure 4)
The current prestige disc replacement has a long history. Its initial design was taken from the
technology developed by Cummins et al. and acquired by Medtronic Sofamor Danek (Mem‐
phis, Tennessee). Over many derivations the implant has morphed from a stainless steel ball
and socket articulation into a cobalt chrome alloy with a ball and groove design. This allows
for coupled motion. The implant uses locking screws as well as grit blasted implant surfaces
for fixation. In its most recent design change the Prestige LP moved to titanium ceramic
composition and traded the flange and locking screw construct for a titanium plasma spray
with rails for immediate fixation.
2.5. Mobi-C (Figure 5)
The Mobi-C LDR spine (Austin, Texas) is a metal on the UHMWPE device. It has mobile
bearing technology allowing both the superior and inferior endplates to articulate with the
polyethylene for an increased range of motion. The articulation between the insert and the
inferior endplate is limited by two lateral stops on the inferior endplate. The endplates, made
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of cobalt chromium alloy, are coated with plasma sprayed titanium and a hydroxyapatite
coating to promote ingrowth.
Figure 5. Mobi-C (Courtesy of LDR, Austin, Texas)
3. Biomechanics
Critical to understanding the biomechanics of cervical disk replacement is a knowledge of
normal cervical spine kinematics. Normal motion in the subaxial cervical spine requires
Figure 4. Evolution of the Prestige Cervical Disc (Courtesy of Medtronic Sofamor Danek, Memphis, Tennessee)
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coupled motions at the disc space. There is anterior-posterior translation during flexion and
extension as well as lateral translation during bending and axial rotation. Secondary to this
complex motion is the concept of varying constraint through normal cervical spine range of
motion. During flexion the facet joints unshingle and provide less constraint across the
involved disc. During extension the opposite occurs and the motion segment becomes more
constrained. Understanding the varying amounts of constraint in the native disc is vital when
considering the concept of constraint within an implant. Huang et al. [12] defines constraint
in the cervical spine as a limitation of anterior-posterior translation typically found during
normal flexion and extension activity. An unconstrained or semi-constrained device theoret‐
ically allows for more natural motion across a given segment. On the other hand, a constrained
implant dictates all motion at that segment and could result in decreased motion and more
stress across the segments as the implant and facet joints work against each other. Additionally,
the complex nature of each motion segment results in varying centers of rotation. Building on
the work of Penning and Amevo [13, 14], the normalized instantaneous centers of rotation
were identified and can be seen in Figure 6 [15]. These centers of rotation become increasingly
important with respect to implant positioning particularly for devices with a more constrained
design. Failure to position the implant appropriately could result in increasing strain on the
facets. Figure 7 demonstrates ideal placement on the lateral view with slightly asymmetric
insertion on the AP. Ideal placement can be seen in figures 13 and 14.
Figure 6. Mean instantaneous axes of rotation for each level of the cervical spine. Circles represent a two standard de‐
viation range of distribution. Knowledge of their location is instrumental for proper placement of CSA implants. (Im‐
age reprinted from Bogduk N, Mercer S. Clin Biomechanics, 2000 [15])
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Figure 7. AP and lateral radiographs of a ProDisc-C
4. Surgical technique
• Patient positioning: Proper positioning is key to proper orientation and alignment of the
prosthesis. Obtaining anatomic lordosis is critical prior to procedure commencement. This
can be achieved with a rolled towel or similar placed behind the neck. Additionally, AP
and  lateral  fluoroscopic  imaging  is  necessary  to  ensure  proper  placement  of  the  im‐
plant. The head should be secured to prevent rotation. The shoulders may be taped with
caudal  retraction  as  necessary  for  visualization.  Figures  8  and  9  demonstrate  proper
positioning.
• Approach and discectomy: A standard Smith-Robinson approach may be utilized and the
index level exposed. The center of the vertebral body must be identified for proper implant
placement (Figure 10). Aggressive hemostasis will help to prevent blood loss and reduce
risk of heterotopic ossification. Additionally, the surgeon must obtain parallel distraction
of the disc space (Figure 11), release the foramen bilaterally, and re-establish normal disc
height prior to implant placement.
• Device insertion: Implant placement and fixation should be done under fluoroscopic
guidance utilizing implant specific devices as outlined in each respective technique guide
(Figure 12). The surgical site should be thoroughly irrigated and closed in a standard fashion.
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Figure 8. Illustrations of proper positioning for cervical disc replacement (Courtesy of Synthes Spine, West Chester,
Pennsylvania)
Figure 9. Illustrations of proper positioning for cervical disc replacement (Courtesy of Synthes Spine, West Chester,
Pennsylvania)
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Figure 10. Illustrations of midline identification of the vertebral body and parallel distraction of the disc space for opti‐
mal implant placement (Courtesy of Synthes Spine, West Chester, Pennsylvania)
Figure 11. Illustrations of midline identification of the vertebral body and parallel distraction of the disc space for opti‐
mal implant placement (Courtesy of Synthes Spine, West Chester, Pennsylvania)
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Figure 12. Lateral fluoroscopic view demonstrating optimal trial placement along the posterior margin of the vertebral
bodies. Note the parallel distraction of the endplates and placement of the distraction pins. (Courtesy of Synthes Spine,
West Chester, Pennsylvania)
Figure 13. Intra-operative views showing optimal placement of cervical disc arthroplasty in the AP and lateral views
(Courtesy of Synthes Spine, West Chester, Pennsylvania)
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Figure 14. Intra-operative views showing optimal placement of cervical disc arthroplasty in the AP and lateral views
(Courtesy of Synthes Spine, West Chester, Pennsylvania)
5. Clinical outcomes
Most of the data available surrounding CDA, at least in the US, is the result of numerous clinical
evaluations as part of the US FDA IDE studies. This data from these individual studies has
been summarized previously by many authors and will be touched on later in this section.
Some of the most recent data comes in the form of meta-analyses of these existing studies as
well as retrospective review of large clinical databases.
McAfee et al. [16] performed a meta-analysis of four FDA IDE studies examining four separate
CDA devices. At 24 months, over 1200 patients were available across all studies for evaluation.
Pooling all this data, a significant treatment effect favoring arthroplasty was demonstrated
with an overall success rate of 78% for CDA compared to 71% for ACDF. This significance was
also borne out in the subcomponent analysis for neurological status and survivorship. Their
overall conclusions suggest superiority of CDA compared to ACDF.
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Gao et al. [17] reviewed 27 randomized clinical trials. Twelve of these demonstrated level 1
evidence with the remaining studies identified as level 2. The arthroplasty group had lower
VAS neck and arm pain scores, better neurological success, and fewer secondary procedures.
The remaining variables including duration of hospital stay, NDI, and rates of adverse events
demonstrated no significant difference across the groups.
Davis et al. [18] reported a four year follow up on 2-level disc replacement versus ACDF. This
study is part of the US FDA IDE study evaluating the Mobi-C device. Of the 225 patients
receiving CDA, 202 were available for follow up along with 89 of the original 105 patients
receiving ACDF. ASD was found in 86% of ACDF cases compared with 42% of CDA cases.
Rates of subsequent surgeries were also elevated in the ACDF group at 15% compared to 4%
with CDA. From the baseline, CDA patients improved more in NDI, SF-12, patient satisfaction,
and overall success when compared to ACDF. Another study, again looking at the Mobi-C
device in single-level constructs over the course of four years identified significantly higher
rates of subsequent surgery and adjacent segment disease is the ACDF group when compared
to CDA [19]. At no point during this study were CDA scores significantly worse than ACDF
scores with respect to NDI, VAS, or SF-12.
Heller et al. [20] published two-year results on the Bryan FDA IDE study. They had over 200
in each group available at follow up. At two years, the Bryan patients had improved NDI
scores, VAS scores, and higher overall success when compared to ACDF. The longest follow-
up study of the Bryan disc comes from the work of Goffin and his colleagues out of Europe
[21]. This was a multicenter, prospective, non-randomized study, which included both multi-
level and single-level constructs. At their 4-6-year follow up, there were 89 single-level patients
and nine two-level patients available for examination. All patients remained clinically
improved compared to preoperatively. Nearly 90% had good or excellent results based on
Odum’s criteria. Kaplan-Meier analysis showed and estimated success rate over 90% at the
seven-year mark.
The Prestige disc (ST or LP) does not have the long-term data yet to match the longer but non-
randomized study of the Bryan disc. Mummaneni et al. [22] presented the results of the Prestige
ST at two years. Again, this data was from a prospective, randomized, multicenter trial
between ACDF and CDA. With better than 75% follow up, the rate of adjacent level surgery
was statistically greater for the ACDF patients versus the CDA group. This trend continued
with respect to neurological success favoring CDA in 93% of patients compared to 84% of
ACDF patients. Overall success including improved NDI, maintained neurological improve‐
ment, and the absence of implant related adverse events again favored CDA 79% vs. ACDF
68%. SF-36, VAS, and NDI showed no differences at the two-year time point. A two-year
prospective trial out of Japan showed no difference between ACDF and CDA with the Prestige
LP when evaluating VAS, NDI, SF-36, or Japanese Orthopedic Association scores [23].
Data on the ProDisc-C IDE study comes from Murrey et al. [24]. Similar to previous studies
the 1:1 randomized, controlled, multicenter trial had over 100 patients available in each arm
at two-year follow up. Each group had improvement in the clinical parameters measured but
no significant difference was elucidated between groups. Rates of revision surgery, however,
did favor the CDA group (2%) compared to ACDF (8.5%). Delamarter in 2010, re-examined
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the ProDisc-C IDE data in addition to 136 patients that received CDA in the continued access
arm of the study [25]. Again, clinical parameters improved significantly from baseline in both
groups. Mirroring the work of Murrey et al., the rates of secondary surgical procedures were
higher in those patients receiving ACDF (11%) vs. CDA (3%). Half of these ACDF patients
required adjacent segment surgery while the other half required revision ACDF for pseu‐
darthrosis at the index level. While three CDA patients required conversion to fusion for axial
pain, none required surgical intervention at adjacent segments.
Phillips et al. [26] most recently published on the two-year results of the PCM US FDA IDE
clinical trial. At two years the follow-up rate was nearly 90% (195) for the PCM group and 82%
(151) for the ACDF group. Similar to data presented previously, all patients had significant
improvement from baseline in clinical scores. The mean NDI was significantly lower in the
CDA group compared to ACDF (p=0.029). Reported dysphagia scores were also lower in the
CDA group. Overall success rates determined by combined NDI scores, lack of complications,
no need for revision surgery, and radiographic evidence of motion (PCM) and fusion (ACDF)
favored PCM (75%) over ACDF (65%) with a p=0.02. Overall findings from this study suggest
at minimum an equivalency between ACDF and CDA with the PCM device.
In 2008, Riew et al. examined the effectiveness of CDA in the setting of myelopathy due to
single level disc herniation [27]. This study combined subset data from both the Bryan trial
and the Prestige trials. Myelopathy was diagnosed based on hyperreflexia, presence of clonus,
or a Nurick grade of greater than or equal to 1. Radiographic diagnosis was limited to single-
level disc disease and patients with multi-level lesions were excluded. In comparing myelo‐
pathic patients that underwent CDA vs. ACDF, there was no significant difference between
groups with respect to clinical improvement. This data suggests that CDA is a viable treatment
option for patients with cervical myelopathy resulting from single level pathology.
6. Heterotopic ossification
Heterotopic ossification (HO) is frequently associated with CDA and has a reported prevalence
approaching nearly 70% by some authors [28-34]. Similar to the previously described clinical
results some of the most recent data comes from meta-analysis, which demonstrated an
average prevalence of 45% at one year and 58% at two years [35]. HO is not unique to a single
device. The rates associated with Bryan Disc, Mobi-C, and ProDisc-C are 21%, 53%, and 71%
respectively [33]. Not surprisingly, the risk of HO formation increases with multi-level
instrumentation from 41% to 75% in one reported study [36]. To date, no other causal rela‐
tionship has been elucidated between HO rates and diagnosis, alcohol, tobacco, operative level,
operative time, or pre-existing ossified lesions [29, 34]. Secondary to its increasing prevalence
a classification scheme was proposed by McAfee et al. [37] adapted from systems previously
used to describe hip and lumbar spine HO. This simple system attempts to quantify the amount
of HO while qualifying the remaining motion at the involved segment [Table 1].
Briefly, grade 0 shows no HO, while grade IV represents complete ankylosis across the segment
[37]. Incidentally, there is some evidence that post-operative NSAID use may reduce the rates
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of HO formation. Review of the continued access arm of Delamarter et al. [25] in which NSAIDS
were more frequently prescribed demonstrated no ankylosis at the treated level compared
with five grade IV lesions in the initial IDE study at four years. Mehren et al. [28] showed a
two-fold decrease in the rate of grade IV HO between two centers in their multicenter trial in
which NSAIDS were routinely prescribed postoperatively at one site but not at the other.
Currently, there is no published data suggesting a correlation between HO and a negative
clinical outcome following CDA. Barbagallo et al. [38] found HO in over 40% of CDA patients
but no difference in reported functional scoring between groups. Some segmental motion was
preserved in 94% with some grade of HO. It should be noted that current follow-up data on
HO is still short term and the long-term natural history as well as its implications for index
level and adjacent level motion remains to be seen.
Class Description
0 No HO present
I HO present but is not in the disc space and does not appear to interferewith motion
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Class Description
II HO has violated the disc space and may be affecting the normal functionof the prosthesis
III Bridging ossifications may limit function of the implant, but motionremains
IV Bridging HO resulting in complete fusion of the segment
Table 1. Classification of HO Scale with computed tomography images (Adapted from [37])
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Figure 15. Lateral radiograph of ProDisc-C with HO formation and preserved motion
7. Complications, infection, and wear
To date, none of the large clinical series have reported catastrophic neurological complications.
As described above, the rates of revision surgery at the index level have been on par or better
when compared with ACDF in a non-inferiority study design. The authors are unaware of any
published reports of CDA revision secondary to infection.
No chapter on arthoplasty would be complete without a discussion on wear and osteolysis.
According to work done on the Bryan disc by Anderson et al., [39] the particles generated were
larger than those associated with hip and knee arthroplasty and occurred in a much smaller
volume. In a mouse model there was no evidence of local or systemic inflammatory response.
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A brief search of the literature identified two case reports of local inflammatory response in
the setting of CDA. The first [40] involved return of radicular symptoms following a metal-on-
metal CDA. Repeat MRI revealed a posterior soft tissue mass encroaching on the spinal canal.
Surgical exploration revealed hypertrophic cartilaginous material and chronic inflammatory
debris. The patient was treated with explantation and conversion to ACDF. After revision
surgery, the patient had complete resolution of symptoms. The second case reported by
Tumialan and Gluf [41] recounts a 30-year-old male that developed axial neck pain nine
months postoperatively. Repeat imaging studies revealed progressive osteolysis on the
superior endplate. Infection workup was negative and revision to ACDF was completed
without complication. Examination of the implant showed no abnormal wear characteristics
and the authors hypothesized that the process was related to a local immune response.
Table 2 highlights the most common complications associated with CDA.
Approach Infections, hollow viscera injury, vascular injury, dysphagia
Technique Malposition, improper sizing, migration, end plate fracture, subsidence, heterotopic
ossification (Figure 14), ankylosis (Figure 15)
Implant Heterotopic ossification, implant failure, wear debris (inflammatory response)
Table 2. Complications of Cervical Spinal Arthoplasty
Figure 16. Ankylosis of a cervical disc arthroplasty
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8. Conclusions
Cervical disc arthroplasty has evolved significantly since its introduction over 60 years ago.
Multiple randomized, controlled, multicenter trials have been performed to assess its validity
compared to the gold standard of ACDF. Unfortunately, despite the large trials the numbers
are still small and the long-term follow up remains to be seen. Recent meta-analyses of existing
data have attempted to extrapolate this data and do show promise for CDA but again only
time will tell.
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